CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIENCY (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2026	Sep. 30, 2025	Sep. 30, 2026	Sep. 30, 2025
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)			47,594,930
Beginning balance	$ (7,550)	$ (17,328)	$ (4,825)	$ (130,328)
Common stock withheld for taxes		(12)		(28)
Stock-based compensation	20	85	129	442
Net income (loss)	$ (3,765)	6,865	$ (6,599)	119,524
Ending balance (in shares)	47,610,653		47,610,653
Ending balance	$ (11,295)	$ (10,390)	$ (11,295)	$ (10,390)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	47,610,653	47,564,607	47,594,930	47,556,267
Beginning balance	$ 482	$ 475	$ 482	$ 475
Issuance of common stock for restricted stock units (in shares)	0	13,695	15,723	26,193
Common stock withheld for taxes, (in shares)		(2,026)		(6,901)
Issuance of common stock upon exercise of stock options (in shares)		2,209		2,926
Ending balance (in shares)	47,610,653	47,578,485	47,610,653	47,578,485
Ending balance	$ 482	$ 475	$ 482	$ 475
Common To Be Issued
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	2,701	2,701	2,701	2,701
Beginning balance	$ 0	$ 0	$ 0	$ 0
Ending balance (in shares)	2,701	2,701	2,701	2,701
Ending balance	$ 0	$ 0	$ 0	$ 0
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	349,307	348,901	349,198	348,560
Common stock withheld for taxes		(12)		(28)
Stock-based compensation	20	85	129	442
Ending balance	349,327	348,974	349,327	348,974
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(357,339)	(366,704)	(354,505)	(479,363)
Net income (loss)	(3,765)	6,865	(6,599)	119,524
Ending balance	$ (361,104)	$ (359,839)	$ (361,104)	$ (359,839)